Researcher | Research Overview
Dr. Rodan’s research interests include MRI pattern recognition and functional MRI studies in the diagnosis and management of neurometabolic disorders. He is currently a sub-investigator for 2 ongoing clinical trials at Boston Children’s Hospital, and has also continued his work as a clinician in the Harvard Undiagnosed Diseases Network (UDN).
Researcher | Research Background
Dr. Rodan completed a residency in Pediatric Neurology at the Hospital for Sick Children in Toronto, Canada. He also obtained certification in EEG electrophysiology through the Canadian Society of Clinical Neurophysiologists (CSCN). He then completed fellowships in both Clinical Genetics and Medical Biochemical Genetics at Harvard Medical School. He participated in the Harvard Undiagnosed Diseases Network (UDN) program from July 2015-June 2016. Dr. Rodan’s particular areas of interest are in the fields of Neurometabolism and Neurogenetics. He has a busy clinical practice at Boston Children’s Hospital, where he sees patients in both Genetics/Metabolism and Neurology clinics.
Selected Publications
Rodan LH, Gibson KM, Pearl PL. Clinical Use of CSF Neurotransmitters. Pediatr Neurol 2015.
Rodan LH, Berry GT. N-acetylcysteine therapy in an infant with transaldolase deficiency is well tolerated and associated with normalization of alpha fetoprotein levels. JIMD Reports 2016.
Rodan LH, Cohen J, Fatemi A, Gillis T, Lucente D, Gusella JF, Picker JD. A novel neurodevelopmental disorder associated with compound heterozygous variants in the huntingtin gene accepted for publication in European Journal of Human Genetics 2016.
Rodan LH, Moufawad El Acktar C, Berry GT, Poduri A, Prabhu SP, Yang E, Anselm I. De Novo TUBB2A variant presenting with Anterior Temporal Pachygyria. Journal of Child Neurology 2016.